161 Pembrolizumab plus chemoradiotherapy for high-risk locally advanced cervical cancer: the randomized, double-blind, phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 study

Domenica Lorusso, Yang Xiang,Kosei Hasegawa, Giovanni Scambia, Manuel Leiva, Pier Ramos-Elias, Alejandro Acevedo, Julia Vizkeleti, Andrea Gomes, Fernando Contreras Mejía, Ari Reiss,Ali Ayhan,Jung-Yun Lee, Valeriya Saevets,Flora Zagouri,Kan Li, Karin Yamada, Sarper Toker, Sandro Pignata,Linda R Duska

Oral Sessions（2024）

Cited 0|Views24

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined